Company Profile

^{Recent news}

"Pharmacological inhibition of Akt and downstream pathways modulates the

expression of COX-2 and mPGES-1 in activated microglia." - Published in:
J Neuroinflammation

2012 Jan 3

^{Opinions from our customers:}

Dr. G. Weiss (PASCOE pharmazeutische Praeparate GmbH):

"We cooperate very well since many years and learned to appreciate VivaCell as a reliable and competent co-operation partner in pre-clinical research. Therefore we are looking forward to continue our successful partnership."

Company Profile:

Vivacell Biotechnology GmbH is a privately owned contract-based research organisation (CRO) that provides specialised in vitro and in vivo models for testing and developing pharmaceutical and phytopharmaceutical compounds.

Additional services for clinical trials and marketing studies are offered.

VivaCell’s preclinical services include standard protocols and protocols adapted to the needs of the customers using a variety of in vitro and in vivo systems.

VivaCell is combining highly qualified cellular and molecular biology knowledge and expertise in various fields with a focus on immunology and neurobiology.

At VivaCell we offer you complete research projects from basic R&D up to pre-clinical research (GLP) in one hand. Our clients do not have to gather the research data form various CROs.